LIQUIDIA TECHNOLOGIES INC

LQDA NASDAQ
5.17
-0.49
-8.66%
After Hours: 5.05 -0.12 -2.32% 16:33 08/23 EDT
Open
5.61
Prev Close
5.66
High
5.70
Low
5.12
Volume
124.14K
Avg Vol (3M)
76.70K
52 Week High
38.46
52 Week Low
4.940
% Turnover
0.82%
Market Cap
78.14M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers LIQUIDIA TECHNOLOGIES INC LQDA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company, which is focused on the developing and commercialization of human therapeutics using its PRINT technology. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The Company is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865, has completed a Phase Ib clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.
MORE >

Recently

Name
Price
%Change